Target intelligence / Profile preview

Calpain-2 Catalytic Subunit (CAPN2)

Target
CAPN2
Molecular classification
Enzyme, Cysteine protease, Peptidase
01

Overview

The calpain-2 catalytic subunit is a calcium-dependent cysteine protease that plays a role in various cellular processes, including cytoskeletal remodeling, signal transduction, and apoptosis. It is implicated in several diseases, including cardiac disease, hepatic fibrosis, and neurodegenerative disorders. The enzyme is activated by calcium binding and undergoes autolytic processing, and its activity is regulated by the endogenous inhibitor calpastatin. Targeting CAPN2 may present therapeutic challenges due to its broad substrate specificity and essential physiological functions.

Other names
m-calpainmilli-calpain
02

Mechanism of action

Calpain-2 is a calcium-dependent cysteine protease involved in limited proteolysis of various substrates. Drugs targeting this molecule typically aim to inhibit its proteolytic activity, preventing its involvement in disease-related pathways.

03

Biological functions

Calcium ion bindingCysteine-type peptidase activityMetal ion bindingCytoskeletal protein bindingCytoskeletal remodelingSignal transductionApoptosisTranscriptional regulationProteolysis
04

Disease associations

Cardiac diseaseHepatic fibrosisIschemia-reperfusion injuryHeart failureCancerNeurodegenerative disease
05

Safety considerations

Potential for off-target effects due to the broad substrate specificity of calpains.Inhibition of calpain-2 may disrupt essential physiological processes.Over-inhibition of calpain-2 might disrupt normal calcium homeostasis.

Beyond the preview

Go deeper on Calpain-2 Catalytic Subunit (CAPN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calpain-2 Catalytic Subunit (CAPN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call